ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 133 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,962,000 | +25.7% | 124,177 | +1.0% | 0.07% | +39.6% |
| Q1 2018 | $1,561,000 | -61.4% | 122,900 | -65.2% | 0.05% | -54.7% |
| Q4 2017 | $4,043,000 | -25.1% | 353,100 | -19.8% | 0.12% | -34.3% |
| Q3 2017 | $5,396,000 | +260.2% | 440,488 | +871.2% | 0.18% | -13.2% |
| Q4 2015 | $1,498,000 | +20.3% | 45,355 | +19.4% | 0.20% | +632.1% |
| Q3 2015 | $1,245,000 | -55.9% | 38,000 | -28.8% | 0.03% | -62.2% |
| Q2 2015 | $2,826,000 | +136.5% | 53,358 | +28.9% | 0.07% | +146.7% |
| Q1 2015 | $1,195,000 | +236.6% | 41,400 | +239.3% | 0.03% | -14.3% |
| Q4 2014 | $355,000 | +116.5% | 12,202 | -5.5% | 0.04% | +775.0% |
| Q3 2014 | $164,000 | – | 12,914 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
| Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
| PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
| Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
| PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
| Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
| CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
| Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |